Could the Advanced Hybrid Closed-Loop System Algorithm Provide Postprandial Normoglycemia After a High-Fat, High-Protein Meal
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Ege University
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- time spend in time in range (70-180 mg/dl) for postprandial 5 hours after the test meal
Study Overview
Brief Summary
AHCL Systems Could Cover Postprandial Glycemic Response After High Fat and High Protein Meals
Detailed Description
On the 1st, 2nd and 3rd day of the study, a pediatric endocrinologist from the research team will evaluate the continuous glucose measurement system data and optimize the carbohydrate/insulin ratios. On the 4th and 7th days of the study, participants with blood sugar levels between 70-140 mg/dl according to the continuous glucose measurement system, which is a component of the hybrid closed-loop insulin infusion pump system, will consume the test meal consisting of Dr Oetker Ristorante Pizza Mista (340 grams) (92 g carbohydrate, 33 g protein, 41 g fat) at lunch, under the supervision of a dietician from the research team, by switching the pump to manual mode and entering the carbohydrate amount of the meal into the pump. This application will be repeated on the 11th and 14th days of the study while the participant's pump is in automatic mode. Participants will not be allowed to consume food or beverages other than water or exercise for 5 hours after the meal. Blood sugar monitoring will be done with a continuous glucose measurement system. The participant will leave the hospital 5 hours after the start of the meal to return to their normal life. Dr Oetker Ristorante Pizza Mista, which was selected as the test meal, was chosen because it is a macronutrient content that is consumed by young people between the ages of 9-18 and that is similar to the test meals in the world literature and accepted research reports reporting the effect of high-fat and high-protein meals on glycemic response in individuals with diabetes.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 9 Years to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Volunteering to participate in the study
- •Not having a disease accompanying type 1 diabetes (celiac, cystic fibrosis, etc.)
Exclusion Criteria
- •- Not volunteering to participate in the study
- •Using psychiatric medication or any medication that may cause obesity at the time of trial
- •Having a disease accompanying type 1 diabetes (celiac, cystic fibrosis, etc.)
Arms & Interventions
Adolescents with type 1 diabetes on Medtronic Minimed 780G
Each participant will consume the test meal in Medtronic Minimed 780Gmanual mode and Medtronic Minimed 780G in auto mode. Each participant will be in control of himself/herself
Intervention: Test meal (Other)
Adolescents with type 1 diabetes on Medtronic Minimed 780G
Each participant will consume the test meal in Medtronic Minimed 780Gmanual mode and Medtronic Minimed 780G in auto mode. Each participant will be in control of himself/herself
Intervention: Each participant will consume the test meal when on Medtronic Minimed 780G and will consume test meal on Medtronic Minimed 780G on manual mode (Device)
Adolescents with type 1 diabetes on Medtronic Minimed 780G
Each participant will consume the test meal in Medtronic Minimed 780Gmanual mode and Medtronic Minimed 780G in auto mode. Each participant will be in control of himself/herself
Intervention: Advanced hybrid closed loop system mode (Device)
Outcomes
Primary Outcomes
time spend in time in range (70-180 mg/dl) for postprandial 5 hours after the test meal
Time Frame: 1 month
Percentage of time when blood sugar is at 70-180 mg/dl for pst prandial 5 hours after the test meal
Secondary Outcomes
No secondary outcomes reported
Investigators
Yasemin Atik Altinok
Dietician, PhD, Assoc Prof
Izmir Tinaztepe University
